Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital.

Melak Aynalem Tiruneh Adane Solomon Getawa

Published in: Vascular health and risk management (2022)

This study showed that patients with heart disease had prolonged prothrombin time, activated partial thromboplastin time, and thrombocytopenia. Therefore, coagulation parameters are required to be checked regularly to monitor coagulation disorders and their complications in heart disease patients.

Keyphrases

end stage renal disease
pulmonary hypertension
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
palliative care
prognostic factors
emergency department
patient reported outcomes
patient reported
electronic health record